TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare
TG Therapeutics, Inc. Long Term Debt 2016–2025
TG Therapeutics, Inc. annual long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- TG Therapeutics, Inc. long term debt as of December 31, 2025: 245.6M, a 0.50% increase year-over-year.
- TG Therapeutics, Inc. long term debt for 2025 were 245.6M, a 0.50% increase from 2024.
- TG Therapeutics, Inc. long term debt for 2024 were 244.4M, a 143.45% increase from 2023.
- TG Therapeutics, Inc. long term debt for 2023 were 100.4M, a 41.14% increase from 2022.
- TG Therapeutics, Inc. long term debt for 2022 were 71.1M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| TG Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $246 |
| 2024 | $244 |
| 2023 | $100 |
| 2022 | $71 |
| 2021 | $68 |
| 2020 | $30 |
| 2019 | $29 |
TG Therapeutics, Inc. Long Term Debt — FAQ
TG Therapeutics, Inc. (TGTX) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TGTX's long term debt history?
The chart and table above show TG Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.